Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Jul 15, 2016; 8(7): 532-542
Published online Jul 15, 2016. doi: 10.4251/wjgo.v8.i7.532
Published online Jul 15, 2016. doi: 10.4251/wjgo.v8.i7.532
Systematic name | Expression levels vs normal (mean ± SD) | P value | ||
Adenoma | Carcinoma | |||
Laterally spreading types (n = 3) | ||||
1 | hsa-miR-320b | 0.649 ± 0.170 | 0.402 ± 0.146 | 0.00488 |
2 | hsa-miR-320e | 0.666 ± 0.159 | 0.376 ± 0.085 | 0.0213 |
3 | hsa-miR-937-5p | 0.842 ± 0.169 | 1.446 ± 0.253 | 0.0215 |
4 | hsa-miR-574-5p | 1.287 ± 0.477 | 0.881 ± 0.339 | 0.0373 |
5 | hsa-miR-320d | 0.705 ± 0.204 | 0.425 ± 0.108 | 0.0407 |
6 | hsa-miR-320a | 0.645 ± 0.140 | 0.412 ± 0.198 | 0.0417 |
7 | hsa-miR-26b-5p | 1.751 ± 0.307 | 1.003 ± 0.600 | 0.0477 |
8 | hsa-miR-320c | 0.676 ± 0.181 | 0.401 ± 0.072 | 0.0516 |
9 | hsa-miR-361-5p | 1.976 ± 0.124 | 1.469 ± 0.378 | 0.0762 |
10 | hsa-miR-195-5p | 0.729 ± 0.172 | 0.391 ± 0.338 | 0.0772 |
Protruded tumors (n = 3) | ||||
1 | hsa-miR-320d | 1.450 ± 0.388 | 0.805 ± 0.369 | 0.000284 |
2 | hsa-miR-320b | 1.456 ± 0.386 | 0.834 ± 0.362 | 0.00203 |
3 | hsa-miR-375 | 1.312 ± 0.163 | 0.285 ± 0.174 | 0.00492 |
4 | hsa-miR-320e | 1.350 ± 0.278 | 0.772 ± 0.362 | 0.00724 |
5 | hsa-miR-320c | 0.879 ± 0.236 | 0.584 ± 0.219 | 0.0105 |
6 | hsa-miR-320a | 1.262 ± 0.208 | 0.810 ± 0.263 | 0.0110 |
7 | hsa-miR-663a | 0.985 ± 0.786 | 1.317 ± 0.798 | 0.0114 |
8 | hsa-miR-211-3p | 1.634 ± 0.193 | 1.533 ± 0.189 | 0.0129 |
9 | hsa-miR-378i | 1.110 ± 0.223 | 0.640 ± 0.333 | 0.0250 |
10 | hsa-miR-26b-5p | 1.261 ± 0.462 | 0.896 ± 0.360 | 0.0253 |
- Citation: Tadano T, Kakuta Y, Hamada S, Shimodaira Y, Kuroha M, Kawakami Y, Kimura T, Shiga H, Endo K, Masamune A, Takahashi S, Kinouchi Y, Shimosegawa T. MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6. World J Gastrointest Oncol 2016; 8(7): 532-542
- URL: https://www.wjgnet.com/1948-5204/full/v8/i7/532.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i7.532